LarryRichardJunckMD

Neuro-Oncology

Professor of Neurology, Univ of Michigan Medical School

Dr. Junck is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

New York Presbyterian Hospital (Cornell Campus)Residency, Neurology, 1981 - 1983
Stanford Health Care-Sponsored Stanford UniversityResidency, Neurology, 1977 - 1980
Stanford Health Care-Sponsored Stanford UniversityInternship, Internal Medicine, 1976 - 1977
University of Michigan Medical SchoolClass of 1976

Regional Top Doctor Castle Connolly, 2014
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012

PubMed

203 citations
Functional diffusion map as an early imaging biomarker for high-grade glioma: correlation with conventional radiologic response and overall survival.
Daniel A. Hamstra, Craig J. Galbán, Charles R. Meyer, Timothy D. Johnson, Pia C. Sundgren
Journal of Clinical Oncology. 2008-07-10
156 citations
The parametric response map is an imaging biomarker for early cancer treatment outcome
Craig J. Galbán, Thomas L. Chenevert, Charles R. Meyer, Christina Tsien, Theodore S. Lawrence
Nature Medicine. 2009-05-01
329 citations
Progression-free survival: an important end point in evaluating therapy for recurrent high-grade gliomas.
Kathleen R. Lamborn, W. K. Alfred Yung, Susan M. Chang, Patrick Y. Wen, Timothy F. Cloughesy
Neuro-Oncology. 2008-04-01

ZD1839 For Recurrent/ Progressive Malig Astrocytoma, Glioblastoma, &MeningiomaNational Center For Research Resources2004
Phase I/II Trial Of CCI-779 (Nsc# 683864) In Patients W/ Malignant GliomaNational Center For Research Resources2004
Phase I/II Trial Cpt-11&Temozolomide(Temodar)In Pts.W/Malignant Glioma Umcc 0048National Center For Research Resources2004
Phase II Study Of Su101 For Patients With Anaplastic ASTNational Center For Research Resources2000–2002
Su101 Versus Procarbazine For First Relapse Patients W/ GlioblastomaNational Center For Research Resources1999–2002
Regional Brain Activation In Patients With Brain TumorsNational Center For Research Resources1996–2002
PET Growth Kinetics And Neuropathology Of Brain TumorsNational Cancer Institute1991–1994
PETT Studies Of Brain MetabolismNational Institute Of Neurological Disorders And Stroke1988
PET Studies Of Brain MetabolismNational Institute Of Neurological Disorders And Stroke1985–1987